The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential.
|Articles|November 1, 1998
The American Journal of Managed Care
- November 1998
- Volume 4
- Issue 11
Ventricular Arrhythmias and the Use of Antiarrhythmic Drugs After Cardiovascular Surgery
Author(s)Brian Olshansky, MD
Advertisement
Articles in this issue
almost 28 years ago
The Ethical Dilemma of Population-Based Medical Decision Makingalmost 28 years ago
Methods of Evaluation in Outcomes ResearchAdvertisement
Related to this article
ALIS added to azithromycin and ethambutol raised culture conversion in new MAC lung disease, with rare resistance, in an ENCORE analysis at IDWeek 2026.
A real-world trial found 42.6% of patients with severe hand eczema cleared on oral alitretinoin.
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access.
IDWeek 2026 posters describe a rule-based tool classifying about 1 in 5 patients with cUTI as outpatient-eligible and 5 clusters with varied LOS.
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, and quality of life.
An international eDelphi panel of 62 dermatologists agreed on a 2-step algorithm for tapering psoriasis biologics.
Real-world data from CHEST 2026 show ETI improved lung function and BMI in children with CF aged 6 to 11, with the most gains in F508del homozygotes.
Advertisement
Advertisement
Trending on AJMC
1
Awareness Gaps Drive Narcolepsy, IH Delays: Logan Schneider, MD
2
Administrative Burden Keeps Clinicians From Bedside: Amy Morris, MD
3
International Panel Agrees on Framework for Tapering Psoriasis Biologics
4
Extension Studies in TPIP Show Promise in PAH, PH-ILD
5